Baxion
Screening
Tags
Alerts
Theme
Pyxis Oncology, Inc.
PYXS
·
NASDAQ
·
$1.63
Share Price as of 11/2
·
$103M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/13/26
10-Q
Q1 ended 03/31/26
05/14/26
10-K
FY 2025
03/23/26
10-Q
Q3 ended 09/30/25
11/03/25
10-Q
Q2 ended 06/30/25
08/14/25
Disclosures
Filter
8-K
Current report
10/01/26
8-K
Current report
09/09/26
8-K
Current report
09/08/26
8-K
Current report
08/13/26
8-K
Current report
07/02/26
Prospectuses and Registrations
Filter
424B5
Prospectus supplement
10/01/26
424B5
Prospectus supplement
09/29/26
424B5
Prospectus supplement
09/29/26
424B2
Prospectus for primary offering
08/28/26
S-3
Shelf registration
08/20/26
Proxies
Filter
DEF 14A
Definitive proxy
10/21/26
PRE 14A
Preliminary proxy
10/09/26
DEF 14A
Definitive proxy
04/30/26
DEFA14A
Additional proxy materials
04/30/26
DEF 14A
Definitive proxy
04/29/25
Ownership
Filter
4/A
Insider transaction (amended)
10/09/26
SC 13G/A
Beneficial ownership (amended)
10/09/26
SC 13G
Beneficial ownership
10/05/26
Form 4
Insider transaction
10/02/26
SC 13G/A
Beneficial ownership (amended)
10/02/26
Other
Filter
EFFECT
Request for effectiveness
08/27/26
ARS
Annual report to shareholders
04/30/26
EFFECT
Request for effectiveness
12/09/25
CORRESP
Correspondence with the SEC
12/08/25
ARS
Annual report to shareholders
04/26/24
Latest Filings
Filter
DEF 14A
Definitive proxy
10/21/26
PRE 14A
Preliminary proxy
10/09/26
8-K
Current report
10/01/26
424B5
Prospectus supplement
10/01/26
424B5
Prospectus supplement
09/29/26
Ownership
Filter
4/A
Insider transaction (amended)
10/09/26
SC 13G/A
Beneficial ownership (amended)
10/09/26
SC 13G
Beneficial ownership
10/05/26
Form 4
Insider transaction
10/02/26
SC 13G/A
Beneficial ownership (amended)
10/02/26